Host: |
HEK293 cells |
Reactivity: |
Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Recombinant-Mouse Osteopontin/SPP1-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications. |
Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
Spp1 |
Gene ID: |
20750 |
Uniprot ID: |
OSTP_MOUSE |
Immunogen Region: |
Leu17-Asn294 |
Immunogen: |
Recombinant Mouse Osteopontin/SPP1 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Leu17-Asn294) of mouse Osteopontin/SPP1 (Accession #NP_033289.2) fused with a 6×His tag at the C-terminus. |
Function | Major non-collagenous bone protein that binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix. Probably important to cell-matrix interaction. Acts as a cytokine involved in enhancing production of interferon-gamma and interleukin-12 and reducing production of interleukin-10 and is essential in the pathway that leads to type I immunity. |
Protein Name | Osteopontin2arBone Sialoprotein 1Calcium Oxalate Crystal Growth Inhibitor ProteinEarly T-Lymphocyte Activation 1 ProteinMinopontinSecreted Phosphoprotein 1Spp-1 |
Database Links | Reactome: R-MMU-1474228Reactome: -MMU-186797Reactome: -MMU-216083Reactome: -MMU-381426Reactome: -MMU-8957275 |
Cellular Localisation | Secreted |
Alternative Protein Names | Osteopontin protein2ar proteinBone Sialoprotein 1 proteinCalcium Oxalate Crystal Growth Inhibitor Protein proteinEarly T-Lymphocyte Activation 1 Protein proteinMinopontin proteinSecreted Phosphoprotein 1 proteinSpp-1 proteinSpp1 proteinEta-1 proteinOp proteinSpp-1 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance